These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29322992)

  • 1. CARASIL, a rare genetic cause of stroke in the young.
    Devaraddi N; Jayalakshmi G; Mutalik NR
    Neurol India; 2018; 66(1):232-234. PubMed ID: 29322992
    [No Abstract]   [Full Text] [Related]  

  • 2. CARASIL families from India with 3 novel null mutations in the
    Preethish-Kumar V; Nozaki H; Tiwari S; Vengalil S; Bhat M; Prasad C; Onodera O; Uemura M; Doniparthi S; Saini J; Nashi S; Polavarapu K; Nalini A
    Neurology; 2017 Dec; 89(23):2392-2394. PubMed ID: 29101275
    [No Abstract]   [Full Text] [Related]  

  • 3. A CARASIL Patient from Americas with Novel Mutation and Atypical Features: Case Presentation and Literature Review.
    Ibrahimi M; Nozaki H; Lee A; Onodera O; Reichwein R; Wicklund M; El-Ghanem M
    Cerebrovasc Dis; 2017; 44(3-4):135-140. PubMed ID: 28628911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically Confirmed CARASIL: Case Report with Novel HTRA1 Mutation and Literature Review.
    Yu Z; Cao S; Wu A; Yue H; Zhang C; Wang J; Xia M; Wu J
    World Neurosurg; 2020 Nov; 143():121-128. PubMed ID: 32445900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monogenic causes of stroke: now and the future.
    Tan RY; Markus HS
    J Neurol; 2015 Dec; 262(12):2601-16. PubMed ID: 26037017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Leukoencephalopathy and Small Vessels Disease Caused by a Novel HTRA1 Homozygous Mutation.
    Gündüz T; Demirkol Y; Doğan Ö; Demir S; Akçakaya NH
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104354. PubMed ID: 31494012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASIL.
    Nozaki H; Kato T; Nihonmatsu M; Saito Y; Mizuta I; Noda T; Koike R; Miyazaki K; Kaito M; Ito S; Makino M; Koyama A; Shiga A; Uemura M; Sekine Y; Murakami A; Moritani S; Hara K; Yokoseki A; Kuwano R; Endo N; Momotsu T; Yoshida M; Nishizawa M; Mizuno T; Onodera O
    Neurology; 2016 May; 86(21):1964-74. PubMed ID: 27164673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Chinese CARASIL Patient Caused by Novel Compound Heterozygous Mutations in HTRA1.
    Xie F; Zhang LS
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2840-2842. PubMed ID: 30068478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep Gray Matter Iron Deposition and Its Relationship to Clinical Features in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Patients: A 7.0-T Magnetic Resonance Imaging Study.
    Sun C; Wu Y; Ling C; Xie Z; Kong Q; Fang X; An J; Sun Y; Zhang W; Yang Q; Wang Z; Zhang Z; Yuan Y
    Stroke; 2020 Jun; 51(6):1750-1757. PubMed ID: 32397933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation in the HTRA1 gene identified in Chinese CARASIL pedigree.
    Wang XL; Li CF; Guo HW; Cao BZ
    CNS Neurosci Ther; 2012 Oct; 18(10):867-9. PubMed ID: 22900900
    [No Abstract]   [Full Text] [Related]  

  • 11. Two novel HTRA1 mutations in a European CARASIL patient.
    Bianchi S; Di Palma C; Gallus GN; Taglia I; Poggiani A; Rosini F; Rufa A; Muresanu DF; Cerase A; Dotti MT; Federico A
    Neurology; 2014 Mar; 82(10):898-900. PubMed ID: 24500651
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL)].
    Uemura M; Nozaki H; Onodera O
    Brain Nerve; 2017 Jan; 69(1):25-33. PubMed ID: 28126975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lumbago and alopecia in a patient with leukodystrophy: think on CARASIL.
    Souza PV; Pinto WB; Oliveira AS
    Arq Neuropsiquiatr; 2016 Jul; 74(7):599-600. PubMed ID: 27487381
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Liu et al.: Loss of TGF-β signaling in CARASIL pathogenesis.
    Beaufort N; Scharrer E; Lux V; Ehrmann M; Haffner C; Dichgans M
    Proc Natl Acad Sci U S A; 2015 Apr; 112(14):E1694. PubMed ID: 25770223
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel HTRA1 exon 2 mutation causes loss of protease activity in a Pakistani CARASIL patient.
    Khaleeli Z; Jaunmuktane Z; Beaufort N; Houlden H; Haffner C; Brandner S; Dichgans M; Werring D
    J Neurol; 2015 May; 262(5):1369-72. PubMed ID: 25957642
    [No Abstract]   [Full Text] [Related]  

  • 16. A frameshift mutation in HTRA1 expands CARASIL syndrome and peripheral small arterial disease to the Chinese population.
    Cai B; Zeng J; Lin Y; Lin Y; Lin W; Lin W; Li Z; Wang N
    Neurol Sci; 2015 Aug; 36(8):1387-91. PubMed ID: 25772074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of HtrA1-induced attenuation of TGF-β signaling in fibroblasts might not be the main mechanism of CARASIL pathogenesis.
    Liu J; Dong F; Hoh J
    Proc Natl Acad Sci U S A; 2015 Apr; 112(14):E1693. PubMed ID: 25770224
    [No Abstract]   [Full Text] [Related]  

  • 18. A new Chinese family with HTRA1 mutation associated with CARASIL.
    Sun D; Tian F; Zhang S; Zhang M
    Neurol Sci; 2022 Jul; 43(7):4577-4579. PubMed ID: 35441934
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutation in the HTRA1 gene in a patient with degenerated spine as a component of CARASIL syndrome.
    Bayrakli F; Balaban H; Gurelik M; Hizmetli S; Topaktas S
    Turk Neurosurg; 2014; 24(1):67-9. PubMed ID: 24535794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygous HTRA1 mutations with mimicking symptoms of CARASIL in two families.
    Kono Y; Nishioka K; Li Y; Komatuzaki Y; Ito Y; Yoshino H; Tanaka R; Iguchi Y; Hattori N
    Clin Neurol Neurosurg; 2018 Sep; 172():174-176. PubMed ID: 30031255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.